Roche's Michael Forstner spoke at the World Drug Safety Congress Europe and Americas in 2011. Following up to his interview in the blog last week I wanted to focus a bit of what he covered in his previous conference involvement. He brought his in-depth knowledge of pharmacovigilance and risk management to the meetings and has some interesting perspectives. He spoke about benefit risk management for medicines. I wanted to highlight one of the interesting slides that Michael covered in his talk. Its a great visual representation for the criteria for the benefits and the risk of medicines and how they offset each other.
Michael Forstner is already confirmed to speak at the 2012 event and I very much look forward to hearing his update on industry best proactive in risk management.